Three Ways to Transform Pharmaceutical Supply Chains Through Smart, Green Technology with Intelsius

CMC Development: How Early Manufacturing Decisions Prevent Costly Development Delays

Teva's Drug Development Pivot: Dr. Eric A. Hughes EVP, Global R&D and Chief Medical Officer

How Grünenthal Builds Strategic External Supply Relationships with Felipe Furiati

BioRN Reports Surge in US Applications as Scientists Seek New Opportunities - Interview with Dr. Julia Schaft, Managing Director

RFK Jr. Cancels $500M in mRNA Vaccine Development: US Government Abandons Pandemic Platform

From Lab to Patient: How Tetraneuron's Gene Therapy Approach is Tackling Alzheimer's Disease

How Astellas Reset Research Procurement from 200 to 10 Suppliers

From Film to Pharma: Inside FUJIFILM Biotechnologies' $5 Billion Growth Strategy

Follow the Money How Private Equity Capital Flows are Reshaping the CDMO Landscape

Biologics at Scale: Navigating Development & Manufacturing Challenges in an Uncertain World

Gene Therapy at a Crossroads: Novartis Leader Maps the Journey From Hype to Reality

European Small Molecule Manufacturing at Critical Juncture as Green Rules Meet Market Reality

How To Build Biotechs from First Principles: Deep Science Ventures’ Formula for Science-based Innovation

10 Things I’d Do Differently When Fast Tracking Emergency Drug Manufacturing

Six Strategic Imperatives for CDMO-Sponsor Success: Simon Kucher Reveals Critical 2025 Industry Roadmap

Quality as Catalyst: How Risk Culture and Transparency Drive CDMO Success

Axplora Strategy Teardown: Investing in High-Growth Therapeutics with a Customer-Driven Approach

Digital Manufacturing Networks in the Real World

Pharma Supply Chain Disruptions: Rx-360’s Ryan Kelly Shares Critical Best Practices